Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review
Open Access
- 22 November 2018
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (12) , 3702
Abstract
Alzheimer’s disease is the most common form of dementia and is a significant burden for affected patients, carers, and health systems. Great advances have been made in understanding its pathophysiology, to a point that we are moving from a purely clinical diagnosis to a biological one based on the use of biomarkers. Among those, imaging biomarkers are invaluable in Alzheimer’s, as they provide an in vivo window to the pathological processes occurring in Alzheimer’s brain. While some imaging techniques are still under evaluation in the research setting, some have reached widespread clinical use. In this review, we provide an overview of the most commonly used imaging biomarkers in Alzheimer’s disease, from molecular PET imaging to structural MRI, emphasising the concept that multimodal imaging would likely prove to be the optimal tool in the future of Alzheimer’s research and clinical practice.Keywords
This publication has 167 references indexed in Scilit:
- Cognition, glucose metabolism and amyloid burden in Alzheimer's diseaseNeurobiology of Aging, 2012
- Using Pittsburgh Compound B for In Vivo PET Imaging of Fibrillar Amyloid-Beta2012
- Amyloid‐beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B dataAnnals of Neurology, 2011
- Brain atrophy associated with baseline and longitudinal measures of cognitionNeurobiology of Aging, 2011
- Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: An ADNI study of 515 subjectsNeuroImage, 2009
- Amyloid imaging in mild cognitive impairment subtypesAnnals of Neurology, 2009
- Carbon 11–Labeled Pittsburgh Compound B and Carbon 11–Labeled (R)-PK11195 Positron Emission Tomographic Imaging in Alzheimer DiseaseArchives of Neurology, 2009
- Aβ amyloid and glucose metabolism in three variants of primary progressive aphasiaAnnals of Neurology, 2008
- Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stageNeuroImage, 2008
- β‐amyloid burden is not associated with rates of brain atrophyAnnals of Neurology, 2008